Applied Therapeutics Inc expected to post a loss of 26 cents a share - Earnings Preview

Applied Therapeutics

08/08/2023 16:47

* Applied Therapeutics Inc  APLT.OQ   APLT.O  is expected
to show
a rise in quarterly revenue when it reports  results on August
10 (estimated). 
    * The New York City-based  company is expected to report
revenue
of $8 million, according to the estimate from one analyst, based
on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Applied
Therapeutics Inc
is for a loss of 26 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Applied
Therapeutics Inc is $5​, above​ its last closing price of $1.62.
​​​

This summary was machine generated August 8 at 15:46 GMT.  All
figures in US dollars  unless otherwise stated